Latest news
VERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - NewMediaWireNewMediaWire · Thu, 06 Aug 2026 20:49:48 GMTVERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC® Cancer Therapy Platform - NewMediaWireNewMediaWire · Thu, 30 Jul 2026 18:55:50 GMTVERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTVERAXA Biotech (VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTVERAXA Biotech (VRXA) Shareholders Approve Corporate Governance, Financing Measures - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTVERAXA Biotech (VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration - NewMediaWireNewMediaWire · Mon, 27 Jul 2026 19:43:56 GMT